3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Parasomnias
3
Breast Neoplasms
3
Weight Loss
2
Sleep Wake Disorders
2
Lung Neoplasms
2
Cachexia
2
Tuberous Sclerosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smith-Magenis Syndrome
1
Quality of Life
1
Neoplasms
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Fatigue
1
Depression
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer - Female
1
Autism Spectrum Disorder
1
Anxiety Disorders
1
Anorexia
1
Angelman Syndrome
1
Interventions
Therapeutics
6
Escitalopram
4
Yoga
3
Surveys and Questionnaires
3
Sugars
2
Psychiatric Rehabilitation
2
Psilocybin
2
Ketamine
2
Vorinostat
1
Ultraviolet Therapy
1
Typhoid-Paratyphoid Vaccines
1
Therapeutic Touch
1
Temozolomide
1
Self-Help Groups
1
Selective Serotonin Reuptake Inhibitors
1
Saline Solution
1
Psychosocial Intervention
1
Niacin
1
Minocycline
1
Methylphenidate
1
Melatonin
1
Massage
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Interleukin-2
1
Infliximab
1
Imagery, Psychotherapy
1
Fatty Acids, Omega-3
1
Exercise Test
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Depression
×
Melatonin
×
Clear all
NCT01355523
2014-05-06
MELODY
Herlev Hospital
Phase 2/3
Terminated
54 enrolled
27 charts